BLOOD CELL THERAPY / The official journal of APBMT

Not yet evaluated

About the journal

BLOOD CELL THERAPY / The official journal of APBMT is an open-access journal in Japan. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

ISSN
2432-7026
Country
Japan
Access
Open access
Official website
https://bct.apbmt.org/

Index listings

  • PUBMED · 2019-02-25
Indexing
PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

148

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

7

i10-index

3

From OpenAlex open data (CC0).

Editorial & policy3
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Identity & continuity3
Alternate titles
official journal of APBMTOfficial journal of Asia-Pacific Blood and Marrow Transplantation
Source type
journal
NLM unique ID (PubMed)
9918333884906676
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • CAR-T cell therapy research
  • CAR-T cell therapy research
Show all subjects (50)
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • Multiple Myeloma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Renal Transplantation Outcomes and Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Renal Transplantation Outcomes and Treatments
  • Cancer survivorship and care
  • Virus-based gene therapy research
  • T-cell and B-cell Immunology
  • Transplantation: Methods and Outcomes
  • Mesenchymal stem cell research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Biomedical Ethics and Regulation
  • Polyomavirus and related diseases
  • Transplantation: Methods and Outcomes
  • Cancer survivorship and care
  • Mesenchymal stem cell research
  • Virus-based gene therapy research
  • Immune Cell Function and Interaction
  • Biomedical Ethics and Regulation
  • Polyomavirus and related diseases
  • T-cell and Retrovirus Studies
  • T-cell and Retrovirus Studies
  • Systemic Sclerosis and Related Diseases
  • Bone and Joint Diseases
  • COVID-19 and healthcare impacts
  • Systemic Sclerosis and Related Diseases
  • Bone and Joint Diseases
  • COVID-19 and healthcare impacts
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: